This content is machine translated CAR-T cells Focus on innovative cancer therapy CAR-T cells are currently one of the most exciting developments in immunotherapy. It combines immunotherapy, cell therapy and gene therapy and could become a routine treatment in the future.
View Post 5 min This content is machine translated Eosinophils Severe asthmatics are more likely to suffer from systemic steroids If a diagnosis of severe asthma is confirmed, adjunctive therapy with monoclonal antibodies may be considered. Currently, anti-IgE or anti-IL5 antibodies are available for this purpose, depending on the phenotype.…
View Post 2 min This content is machine translated Multiple sclerosis Improve quality of life, inhibit disease progression Not only the quality of life, but also mobility and inhibition of progression in multiple sclerosis can be sustainably increased thanks to the latest therapeutic approaches. Immunomodulatory drugs have already…
View Post 5 min This content is machine translated Away from prednisolone - even if the asthmatic swears by it “Wonderful devil stuff” Guideline changes and new therapeutic approaches are leading to changes in approaches to the treatment of severe asthma. In severe, refractory cases, biologics are now clearly preferred over steroids.
View Post 7 min This content is machine translated Dementia Multimorbid dementia patient – what to do? Dementia patients are mostly elderly and multimorbid. Close care that takes comorbidities into account is important – but challenging because of the unique characteristics of these patients.
View Post 4 min This content is machine translated Immunotherapies CAR-T for pemphigus vulgaris as a future therapeutic option? In recent years, great progress has been made in the study of autologous immunocellular therapies. The development of a target-specific chimeric antigen receptor (CAR) against pathogenetic autoreactive B-cell pemphigus vulgaris…
View Post 7 min This content is machine translated Parkinson's disease Improving cognition: “Try tango”. Cognitive impairment is a key factor in patients’ quality of life and independence. How effective are currently approved drugs? And what is happening in the non-pharmacological field?
View Post 5 min This content is machine translated Inflammatory crisis areas Problem zone eyelids Contact allergy is a common cause of eyelid eczema. However, ocular involvement is also a symptom of many chronic inflammatory skin diseases. What are the differential diagnoses to consider? What…
View Post 4 min This content is machine translated Inflammatory dermatoses - from immunology to active substances Quantum leap in target-specific therapy options The treatment spectrum of inflammatory dermatoses has greatly expanded. The 2019 re-approval of risankizumab (psoriasis) and dupilumab (atopic dermatitis) are just some of the milestones. It can be assumed that…
View Post 3 min This content is machine translated Skin microbiome Host-microbiome interactions in atopic dermatitis. Research into the skin microbiome has become increasingly important in recent years. A study presented at the 2019 ADF Annual Meeting examined the effects of topical cortisone externals on the…
View Post 5 min This content is machine translated Type 2 diabetes: SGED recommendations update Reduction of cardiovascular complications as top priority Prevention of microvascular and macrovascular complications is an important overarching goal in the management of type 2 diabetes, and the current SGED guidelines have further informed decision making in cardiovascular…
